Month: July 2023
SPONSORED CONTENT
Demonstrate Compliance with 340B Drug Pricing Requirements, Implement Strategies for Successful Audits, and Provide Quality Care
Designed for both Covered Entities and Manufacturers, attend this event to explore the latest developments in 340B with regards to transparency, HRSA 340B audits and other federal oversight activities. Attendees will examine the impact of recent policy changes, trends in pharmacy contracting and drug management practices, how to effectively leverage data analytics, and strategies to maintain compliance and ensure program integrity.
- Tailor your conference experience through multi-track offerings for covered entities’ and manufacturers’
- Analyze current 340B litigation and its impact on future market dynamics through multi-stakeholder perspectives
- Explore the latest developments in 340B contracting, transparency, HRSA 340B audits and compliance
- Network with senior executives focused on 340B including manufacturers, covered entities, and HRSA grantees
340B INDUSTRY LEADER SPOTLIGHT
Tracy Jones, Midwest Regional Director & National Director of Advocacy, AIDS Healthcare Foundation
Q: Where did you grow up?
I grew up on the Eastside of Cleveland, Ohio in the inner city.
Q: Where did you go to college/graduate school?
I
…Biopharmaceutical manufacturer Genentech, South Dakota-based health system Sanford Health, and South Carolina federally qualified health center Carolina Health Centers are jointly lobbying members of Congress to back six U.S. senators’ bipartisan approach to federal 340B program reform, the three organizations
…